Insulin-deficient rats are characterized by multiple defects in the pathway of glycogen synthesis and breakdown in both liver and skeletal muscle. The aim of this study was to clarify whether islet transplantation under the kidney capsule, which is associated with delivery of insulin into the peripheral circulation, is able to normalize glycogen metabolism in liver and muscle of streptozotocin-diabetic rats. Three groups of male Lewis rats were studied under fasting condition: controls, untreated diabetics, and islet transplanted diabetics. Glycogen content, glucose-6-phosphate concentration, and glycogen synthase activity were measured in both liver and skeletal muscle. Untreated diabetic rats were characterized by an increase in glycogen content of 178% and a reduction of glucose-6-phosphate level of 50%. Both glycogen and glucose-6-phosphate contents were restored to normal in transplanted diabetic rats. Active glycogen synthase (0.35 ± 0.1 nmol/min/mg) and activity ratio (0.22 ± 0.04) were significantly impaired compared with controls (0.99 ± 0.2 nmol/min/mg and 0.43 ± 0.06, respectively) and were normalized by islet transplantation. In the skeletal muscle, glycogen content was similar in the three groups of animals, whereas muscle glucose-6-phosphate level was reduced by 28% and glycogen synthase was in a less active state in the untreated diabetic rats. Both the glucose-6-phosphate concentration and the kinetic profile of glycogen synthase were normalized by islet transplantation. In conclusion, islet transplantation under the kidney capsule corrects the diabetes-induced abnormalities in glycogen and glucose-6-phosphate content and glycogen synthase activity in both liver and skeletal muscle.
INTRODUCTION
Liver glycogen content is higher in diabetic rats in the basal state compared with control rats (65) , likely due to the reduction of glycogenolysis. Such reduction seems Streptozotocin (STZ)-induced diabetes in rats is an animal model similar to human insulin-dependent diabetes.
to be due to the inhibition of glycogen phosphorylase by hyperglycemia (3) . In the liver from STZ-diabetic rats, This model of diabetes is characterized by reduction of muscle glucose uptake, due to decrease in Glut-4 content glycogen synthase (GSase, EC 2.4.1.11), the rate-limiting enzyme in glycogen synthesis, is present in a highly and impairment of insulin-induced transporter translocation (24,39) and by multiple insulin signaling abnormaliinactivated state (4, 28) . A gradual decrease in the active form of GSase has been observed with increasing severties (14, 17, 35, 55) . In STZ-diabetic rats, islet transplantation under the kidney capsule has been shown to correct ity of insulin-deficient diabetes in rats (34) . Both allosteric modulation (26,60) and covalent phosthe diabetes-induced defects in the skeletal muscle glucose transport system (40) and the altered insulin signalphorylation-dephosphorylation of the enzyme (2,47) regulate GSase activity. The interconversion between differing (18, 35) . In the same animals, chronic insulin therapy failed to restore insulin-stimulated muscle glucose transent forms of GSase, phosphorylated at different sites, is regulated by the activities of several specific protein kiport (1,31) and insulin signaling (17) to normal.
Several defects in the pathways of glycogen synthesis nases (43) and phosphatases (20) . GSase is activated by insulin through reduction of its degree of phosphorylaand breakdown have been reported in the liver and skeletal muscle of insulin-deficient rats (12, 13, 29, 49, 52, 65) .
tion (2, 43) . The inactivation of GSase observed in the 104 MATARAZZO ET AL.
liver of diabetic rats has been correlated to the reduced were considered diabetic when nonfasted blood glucose level was >300 mg/dl. The groups of rats were of the activity of glycogen synthase phosphatase (28, 38) , likely due to a decrease in the hepatic content of glucose-6-same age and were studied at the same time. The two groups of diabetic animals differed for duration of disphosphate (G6P), allosteric activator of this enzyme (16) .
In the skeletal muscle from diabetic rats, GSase is in ease: the untreated rats were diabetic for 6 weeks, whereas the transplanted were diabetic for 10 weeks (2 a less active state compared with muscle from normal animals, as shown by low activity ratio and high A 0.5 weeks untreated + 8 weeks treated). This was done in order to be sure that the transplanted diabetic animals for glucose-6-phosphate (G6P) and uridine-diphosphoglucose (UDPG), suggesting decreased affinity for both developed diabetes for 2 weeks before transplanting them. We chose to keep the untreated animals for a little activator and substrate (25). These kinetic changes in GSase are consistent with increased phosphorylation of shorter time because they were expected to become really sick. Nonfasted blood glucose concentration was the enzyme.
In the skeletal muscle from diabetic rats, fasting musmeasured several times in different days in the untreated diabetic rats and in the transplanted diabetic rats before cle glycogen concentration is normal and G6P content is reduced (52), as a consequence of the reduction of transplantation and it was always >300 mg/dl. glucose entry into the skeletal muscle cell (1, 39) .
Islet Isolation and Transplantation

Continuous infusion of insulin via an implanted osmotic minipump or via intrahepatic islet transplantation
Islet isolation and transplantation were performed as previously described (10) . Briefly, under anesthesia with has been shown to increase synthase phosphatase activity with activation of GSase in the liver of STZ-diabetic sodium amobarbital (amytal sodium; Eli Lilly & Co., Indianapolis, IN), a laparotomy was performed and the rats (34); however, these altered pathways were only partially corrected. pancreas was exposed. The common bile duct was legated and the ampulla of Vater was cannulated proxiIslet transplantation under the kidney capsule has been shown to normalize the defects in glucose transport mally with P-50 polyethylene tubing and injected with 10 ml of M-199 medium (GIBCO BRL, Gaithersburg, and insulin signaling in the skeletal muscle of diabetic rats (18, 35, 40) . However, it is not known whether islet MD) containing 1.5 mg of collagenase (type P, Boehringer Mannheim, Mannheim, Germany) per milliliter. transplantation under the kidney capsule is able to normalize the defects in glycogen metabolism and glycogen
The pancreas was dissected from the surrounding tissues, removed, and incubated in a stationary bath for synthase activity observed in the liver and skeletal muscle of diabetic rats. In the current study, we first investi-15-18 min at 30°C. After incubation, the digested tissue was washed with M-199 medium containing 10% newgated glycogen content, G6P concentration, and GSase activity in liver and skeletal muscle from STZ-diabetic born calf serum and filtered through a collector tissue sieve (40 mesh; Fisher Scientific Co., Pittsburgh, PA). rats. Secondly, we evaluated the use of syngenic islet transplantation under the kidney capsule to normalize
The islets were then purified by a density gradient (Histopaque-10077; Sigma Immunochemicals) centrifuged the abnormalities observed in untreated diabetic animals in both liver and skeletal muscle.
at 2500 rpm for 20 min. Islet yield was calculated by taking samples of 100 µl from the final preparation. Ali-
MATERIALS AND METHODS
quots of 2000 islet equivalents each were then prepared.
Animals and Experimental Design
A single aliquot of 2000 freshly isolated islet equivalents was aspirated into a 200-µl pipette tip (USA ScienMale inbred Lewis rats weighing 150-200 g were obtained from Taconic Farms (Germantown, NY) and tific Plastics, Ocala, FL) connected with a 1-ml syringe (Hamilton Co., Reno, NE) and then transferred into used as both islet donors and recipients. All animals were housed at 23°C with a 12-h light/dark cycle and fed ad polyethylene tubing P-50 (Becton Dickinson & Co., Parsipanny, NJ). Under light methoxyflurane (Metofane; libitum for several days before the start of the study. The rats were then randomly divided into three different Pitman-Moore Inc., Mundelein, IL) anesthesia, the left kidney of the recipient rat was exposed through a lumbar groups: controls (n = 5) were left untreated and studied 10 weeks later; untreated diabetic rats (n = 5) were left incision. A capsulotomy was performed on the caudal outer surface of the kidney, and the tip of the tube was untreated for 4 weeks and then they received a single IV injection of 65 mg/kg body weight of streptozocin advanced under the capsule; the tubing was then removed and the capsulotomy was cauterized with a dis-(Sigma Chemical Co., St. Louis, MO) and were studied 6 weeks later; transplanted diabetic rats (n = 5) were posable low-temperature cautery pen (Surgicare, Dayville, CT). made diabetic by a single IV injection of 65 mg/kg body weight of streptozocin, 2-3 weeks later underwent islet After transplantation, the rats were bled every 2-5 days between 0930 and 1030 h. Blood samples were transplantation, and 8 weeks later were studied. Rats collected from the snipped tails using heparinized capilto 10 mM) to calculate the various parameters that describe the kinetics of GSase (A 0.5 for G6P, Hill coeffilary tubes, and blood glucose was determined using a portable glucose meter (One Touch II; Johnson & Johncient, and the activity ratio). The A 0.5 for G6P is the concentration of G6P producing half-maximal activation of son, Milpitas, CA). the enzyme. Hill coefficient has been interpreted as an Experimental Day Procedures index of positive cooperativity between the enzyme and All animals were studied after an overnight fast beits activator. The activity ratio was obtained by dividing tween 0830 and 1030 h. The animals were killed by a the GSase activity in the absence of G6P by that deterblow to the head followed by decapitation, and blood mined at 10 mM G6P. This parameter indicates the perwas collected for serum glucose and insulin determinacentage of active enzyme present in vivo. A low value tion. Decapitation as well as cervical dislocation may indicates a state of relative inactivity and a strong depenaffect phosphorylase a, but the changes in the active dence on G6P for full expression of activity. form of glycogen synthase are modest (62) . On the other We used 0.3 mM UDPG in the assay medium for hand, the use of anesthetics affects metabolism (57). To GSase because this is approximately the physiological obtain tissue extracts for the analysis of GSase activity, concentration of UDPG in rat liver and muscle (53). a random section of the liver and quadriceps muscle was Glycogen Assay freeze clamped using liquid nitrogen. Frozen tissues were powdered and the powder was stored at −80°C.
Glycogen concentration was determined by the amySerum glucose was determined by a glucose analyzer loglucosidase method (22) . Protein concentration was (Yellow Springs Instruments, Yellow Springs, OH). Indetermined by the method of Lowry et al. (32) . sulin concentration was determined with a double antiGlucose-6-Phosphate Assay body radioimmunoassay using pig anti-rat insulin serum, a rat insulin standard, and 125 I-labeled insulin (Linco Re-G6P concentration was measured spectrophotometrisearch, St. Louis, MO).
cally by glucose-6-phosphate dehydrogenase method (36) .
GSase Activity Calculation and Statistical Methods GSase activity was measured by the method of Golden
Hill coefficient and A 0.5 for G6P were determined by et al. (19), as previously described (15) . Samples of liver fitting the data to the Hill equation (56) : powder were homogenized in 9 vol of the homogeniza-
where V is the measured velocity of the enzyme in the ane (Tris)-HCl buffer, 100 mM sodium fluoride, 10 mM presence of subsaturating concentrations of G6P; V 0 is EDTA, 0.5% rabbit liver glycogen, and 5 mM dithiothe enzyme velocity in the absence of G6P; V ∞G6P is the threitol (DTT), pH 7.8] with a high-speed tissue disincalculated velocity at infinite G6P concentration; and n tegrator (Ultra Turrax; Jahnke and Kunkel, Staufen, Geris the Hill coefficient. many) for 30 s (two times) with a 30-s cooling period All calculation was performed by a nonlinear regresbetween homogenizations. The homogenate was centrision analysis using the Enzfitter program (Biosoft, Camfuged at 10,000 × g for 20 min at 4°C. The procedure bridge, UK). Data are presented as means ± SE. Statistiwas the same for muscle but the samples were homogecal comparisons were made by one-way ANOVA. For nized in 12 vol homogenization medium. Supernatant post hoc analysis, Duncan test was used. (25 µl) was added to 50 µl medium, the composition of which was 50 mM Tris-HCl buffer, pH 7.5, 5 mM RESULTS EDTA, 1% glycogen, 0.3 mM uridine 5′-diphosphoglucose (UDPG), 20-30 nCi [ 14 
C]UDPG in the glucose
Blood glucose levels in the nonfasted diabetic animals after islet transplantation are shown in Figure 1 . In moiety (Amersham, Buckinghamshire, UK), and glucose 6-phosphate (G6P; from 0 to 10 mM). After 10 all animals, blood glucose concentration fell after islet transplantation. On the day of the experiment, serum min of incubation at 37°C, 50 µl incubation mixture was applied to a short column containing 2.5 cm anion resin glucose concentrations were significantly higher in the untreated diabetic rats in the basal fasting state com-(Dowex AG 2X8, 100-200 mesh, acetate form) and eluted with distilled water. The eluate was collected into pared with controls and transplanted diabetic rats (452 ± 9, 110 ± 5, 102 ± 3 mg/dl, respectively). a scintillation vial. Enzyme activity was expressed as nanomoles UDPG incorporated into glycogen per minSerum insulin levels were not statistically different in the three groups (controls: 38 ± 12 µU/ml, diabetic rats: ute per milligram protein. Protein concentration was determined in the supernatant. GSase activity was deter-18 ± 6 µU/ml, transplanted rats: 28 ± 3 µU/ml).
The metabolic characteristics of the experimental animined at several concentration of G6P (ranging from 0 Figure 1 . Blood glucose concentration in the diabetic rats before and after islet transplantation. Blood was collected from the snipped tails and glucose concentration was determined using a portable glucose meter. The data in this figure have been previously reported (40) . mals analyzed in this study have been reported elsethan in control rats (0.176 ± 0.04 vs. 0.34 ± 0.5 µmol/g, respectively; p < 0.05). In transplanted diabetic rats, G6P where (40).
concentration was not significantly different from conLiver Glycogen and G6P Concentrations trols (0.295 ± 0.5 µmol/g) (Fig. 2) . As shown in Figure 2 , fasting liver glycogen concenGSase Activity in the Liver tration was significantly higher in untreated diabetic rats compared with controls (1.8 ± 0.28 vs. 0.65 ± 0.16 g/100
The kinetic data of liver GSase are reported in Table  1 . The sensitivity of liver GSase to allosteric activation g, p < 0.05). In transplanted diabetic rats, glycogen concentration was 0.43 ± 0.1 g/100 g (p < 0.05 vs. untreated (A 0.5 for G6P) was similar in control, untreated diabetic, and transplanted diabetic rats (1.9 ± 0.5, 1.9 ± 0.2, 1.4 ± diabetic rats) and it was not significantly different from that found in controls rats (Fig. 2) . Liver G6P concentra-0.4, respectively). Likewise, the Hill coefficient was not different in the three groups. tion in the untreated diabetic rats was significantly lower Figure 2 . Liver glycogen content and glucose-6-phosphate concentration in control, untreated diabetic, and transplanted diabetic rats. Numbers of animals for each group are as in Table 1 . *p < 0.05 vs. control and transplanted diabetic rats. #p < 0.05 vs. control rats. (Fig. 3) . G6P concentration in the untreated diabetic rats was slightly but not significantly 
GSase Activity in Skeletal Muscle
Values are means ± SE. n = number of rats. Activity ratio was obtained by dividing glycogen synthase activity in absence of G6P by
The kinetic properties of muscle GSase activity are that determined at 10 mM G6P.
shown in Table 2 . The Hill coefficient was not statisti-*p < 0.05 vs. controls and transplanted diabetics.
cally different in the three groups. In the untreated diabetic rats, the A 0.5 for G6P was increased compared with the control rats (0.9 ± 0.1 vs. 0.5 ± 0.2 mM, respectively). GSase total activity was not statistically different in
In the transplanted diabetic rats, the A 0.5 for G6P (0.4 ± the three groups of rats (diabetic rats: 1.69 ± 0.2, control 0.07 mM) was similar to that of normal rats and signifirats: 2.28 ± 0.2, transplanted rats: 2.47 ± 0.3 nmol/min/ cantly lower than that of untreated diabetics (p < 0.05). mg). Compared with controls, active GSase was signifiGSase total activity was not different in normal, uncantly lower in diabetic rats (0.35 ± 0.1 vs. 0.99 ± 0.2 treated diabetic, and transplanted diabetic rats (7.8 ± 0.9, nmol/min/mg, respectively, p < 0.05). After islet trans-8.85 ± 0.5, and 7.42 ± 0.7 nmol/min/mg, respectively). plantation, active GSase was significantly higher than in In contrast, the active form of GSase in diabetic animals untreated diabetics (0.83 ± 0.1 nmol/min/mg, p < 0.05) was significantly lower than in controls (1.26 ± 0.17 vs. and it was not significantly different from that found 2.09 ± 0.16 nmol/min/mg, respectively). After islet transin controls. As a consequence, the activity ratio in the plantation, active GSase was significantly higher than in untreated diabetic rats was significantly lower than in diabetic rats (2.37 ± 0.35 nmol/min/mg, p < 0.05) and it controls (p < 0.05). In transplanted diabetic rats the acwas not different from that found in controls. The activtivity ratio was not significantly different from that found ity ratio in diabetic rats was significantly decreased comin the controls. pared with normal rats (0.14 ± 0.02 vs. 0.28 ± 0.04, p < Skeletal Muscle Glycogen and G6P Concentrations 0.05). Islet transplantation restored a normal activity ratio in the diabetic rats (0.32 ± 0.02, p = ns vs. controls, Skeletal muscle glycogen content was not different in normal, untreated diabetic, and transplanted diabetic rats p < 0.05 vs. untreated diabetics). Table 1 . *p < 0.05 vs. untreated diabetic rats. other mechanisms might be involved in the determina-
tion of high glycogen content of the liver in STZ ani-A 0.5 (mM) 0.5 ± 0.2 0.9 ± 0.1* 0.4 ± 0.07 mals (38) . Theoretically, the high basal glycogen conHill coefficient 0.6 ± 0.06 0.6 ± 0.05 0.5 ± 0.03 centration in diabetic animals could be due also to an Activity ratio 0.28 ± 0.04 0.14 ± 0.02* 0.32 ± 0.03 increased rate of glycogen synthesis, secondary to the activation of the glycogen synthase. In normal rats the
Values are means ± SE. n = number of rats. Activity ratio was obinactivation of phosphorylase by glucose leads to deactitained by dividing glycogen synthase activity in absence of G6P by that determined at 10 mM G6P.
vation of synthase phosphatase and therefore to activa-*p < 0.05 vs. control and transplanted diabetics.
tion of GSase. However, low active GSase in spite of low phosphorylase a activity suggests that changes in synthase activation can occur separate from changes in DISCUSSION phosphorylase inactivation (37) . We and others (28,49, 53,65) have found that active GSase is lower in diabetic In the current study, islet transplantation restored several key steps in glycogen metabolism in the liver and than in normal rats, suggesting a decreased rate of glycogen synthesis in diabetic fasted rats. However, to clarin the skeletal muscle of diabetic rats.
We have previously shown that islet transplantation ify the mechanisms underlying glycogen synthesis and storage would require a time course of liver enzyme acunder the kidney capsule is able to correct the abnormal glucose profile, the impaired skeletal muscle glucose tivity and substrate content from the fed to the fasting state, which was not the aim of the current study. transport system, and the multiple signaling abnormalities in STZ-diabetic rats (18, 35, 40) .
We chose to measure both forms of GSase at pH 7.8 because of the convenience, as proposed in various assays Although serum insulin levels did not appear to be different in the three groups of animals, streptozocin rats commonly used for the measurement of GSase. This assay might have underestimated the inactive form of were extremely insulin deficient. The basal levels might seem similar for a series of reasons: a) the animals were GSase. However, we were interested in measuring differences between three groups of animals, and, therein the fasting state and this made the insulin values of the control rats quite low; b) the diabetic animals had an fore, any underestimation might have occurred in measuring GSase activity must be considered equally applied overstimulation of their residual insulin secretion since they had a plasma glucose concentration of over 400 to all measurements performed without effect on the difference between the groups. In addition, our results show a mg/dl. On the other hand, this high glucose level could have been achieved only because of the serious insulin strong difference between control and diabetic animals, which is fully corrected by islet transplantation. deficiency.
We have now found an increase of hepatic glycogen Liver G6P content was reduced by 50% in diabetic rats compared with controls. The G6P concentrations in content of 178% in STZ diabetics compared with controls, confirming similar observations of the literature the liver of the control rats are higher than some of the data of the literature (41). However, similar high levels (65). An increase in hepatic glycogen stores during fasting has been reported in patients with non-insulin-depenhave been found by others (29) . In addition, other authors have demonstrated that G6P levels are different dent diabetes (9) . Similarly, under conditions of hyperglycemia and low insulin concentration that mimic the in control and diabetic animals (53). The inhibition of glycogen breakdown is one of the possible mechanisms metabolic situation occurring in insulin-dependent diabetes, a twofold increase in the rate of hepatic glycogen by which G6P decreases in the liver of fasting diabetic rats. Another mechanism could be the increased hepatic synthesis and reduction of glycogen turnover by 73% has been observed (48) . Under the same conditions, it glucose production, which redirects glucose from the liver to the blood (53). The release of glucose into the has been demonstrated that hyperglycemia per se inhibits net hepatic glycogenolysis through the inhibition of circulation is regulated by the balance of fluxes through glucokinase and G6P. In diabetic rats, a severe impairthe glycogen phosphorylase flux (44) . This finding is consistent with the ability of hyperglycemia to promote ment of hepatic glucokinase and an increased G6P activity have been demonstrated, resulting in an enhanced conversion of phosphorylase a to phosphorylase b (6,60). Similarly, the increase in liver glycogen content in fastrate of dephosphorylation of G6P (53). We found a severe impairment of hepatic GSase in ing STZ-diabetic rats might be explained by inhibition of glycogenolysis as a result of low levels of phospho-STZ-diabetic rats, in line with many other reports (28, 49, 53, 65) . The activity ratio was reduced by 48% in idly and the activation of GSase both by allosteric and covalent mechanism redirects glucose into glycogen (30) . liver from diabetic rats. The inactivated state of GSase has been correlated with reduced activity of glycogen Experiments in transgenic animals have shown that increasing either glucose transport or glycogen synthase synthase phosphatase (28,34), secondary to the reduced level of hepatic G6P (16) . Synthase phosphatase is also results in increased glycogen storage (33, 46) . Insulin resistance in patients with non-insulin-depeninhibited when bound to glycogen (61) , and the increased glycogen content in liver of basal diabetic rats dent diabetes is mainly due to decreased stimulation of muscle glycogen synthesis by insulin (58) . Defects in may inhibit synthase phosphatase activity. Evidence exists for operation of such a mechanism in the rat liver GSase (23, 63, 64, 66) , hexokinase (5,21,27), and glucose transport (7, 8, 54) have been implicated in the reduced (42) , due also to the presence of chronic hypoinsulinemia, which induces a reduced activation of glycogen rate of glycogen synthesis. In the skeletal muscle from STZ-diabetic rats, we found a severely impaired GSase synthase phosphatase 1 (11) .
It might be hypothesized that the G6P concentration activity, as shown by an increased A 0.5 for G6P and a reduced activity ratio. Our data suggest that GSase impresent in the current study should be saturating for GSase and phosphatase. However, it has been reported pairment may be in part due to the decrease in G6P content secondary to decreased glucose transport; however, in fasting STZ-diabetic rats that at G6P concentration similar to the one present in the current study (ϳ300 other intracellular defects might be involved. When phlorizin is used in diabetic rats to reduce plasma glucose, nmol/g) hepatic synthase phosphatases activity is still reduced compared with controls (29) . In addition, in diainsulin-mediated glucose uptake is normalized (31), glucose transport is improved (39) , and meal tolerance and betic rats it has been demonstrated that impaired activation of hepatic glycogen synthase exists despite high peripheral insulin-mediated glucose disposal are normalized (50, 51) . However, defects in muscle GSase are not G6P concentrations (37) . Furthermore, the impaired activation of GSase may be due not only to a decreased reversed (51) , suggesting that the correction of hyperglycemia alone is not able to correct the intracellular synthase phosphatase activity but also to an alteration in glycogen synthase D, which would then be a poor subdefect in glycogen synthesis. In STZ-diabetic rats, islet cell transplantation fully corrects the diabetes-induced strate for synthase phosphatase (61) .
Intraportal injection of pancreatic islet cells in STZdefects in skeletal muscle glucose transport system (40), the changes in multiple insulin signaling proteins (18) , diabetic rats has been shown to increase hepatic synthase phosphatase activity and GSase activity ratio (34) ; and also muscle G6P content and the kinetic profile of GSase. however, enzyme specific activities remained below the control values (34) . Similarly, hepatic glycogen levels in
In conclusion, the present study demonstrates that treatment of STZ diabetes by islet transplantation under the treated diabetic animals were between those obtained from control and untreated diabetic rats (34) . In the curthe kidney capsule fully corrects multiple abnormalities in glycogen metabolism both in liver and skeletal musrent study, hepatic glycogen content and GSase activity were fully normalized in diabetic rats treated with trans-
cle. An adequate insulin delivery into the peripheral circulation obtained by islet transplantation is able to proplantation of pancreatic islets under the kidney capsule, supporting the hypothesis that restoration of glucoseduce exposure of liver and skeletal muscle to adequate insulin concentrations, so that liver glycogen content, regulated insulin secretion into the peripheral circulation is able to normalize glycogen metabolism in liver from liver and muscle G6P content, and GSase activity are fully normalized in STZ-diabetic rats. STZ-diabetic rats, even though the hormone is not delivered into the portal vein.
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